Clinical trial
Combination Chemotherapy Followed By Chemoradiotherapy, With or Without Surgery…
NCT00069953 · Radiation Therapy Oncology Group, Other · Completed
Key facts
| NCT number | NCT00069953 |
|---|---|
| Title | Combination Chemotherapy Followed By Chemoradiotherapy, With or Without Surgery, in Treating Patients With Resectable Locally Advanced Cancer of the Esophagus or Gastroesophageal Junction |
| Official title | A Phase II Study Of Paclitaxel-Based Chemoradiotherapy Regimen With Selective Surgical Salvage For Resectable Locoregionally Advanced Carcinoma Of The Esophagus |
| Lead sponsor | Radiation Therapy Oncology Group, Other |
| Collaborators | National Cancer Institute (NCI) NIH NRG Oncology |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Esophageal Cancer |
| Intervention type | Biological, Drug, Procedure, Radiation |
| Interventions | filgrastim, pegfilgrastim, cisplatin, fluorouracil, paclitaxel, conventional surgery, radiation therapy |
| Enrollment | 43 |
| Start date | Sep 1, 2003 |
| Primary completion | Mar 1, 2007 |
| Completion | Dec 1, 2016 |
| First posted | Oct 7, 2003 |
| Last update posted | Feb 17, 2017 |
| Countries | United States |
At a glance
- 10–99 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: